Showing 611-620 of 1205 results for "".
ASDS Highlights
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/asds-highlights/35226/Experts from around the world discussed the latest aesthetic treatments as well as what’s coming at the recent ASDS Annual Meeting.Embracing the Diversifying Aesthetics Market
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/embracing-the-diversifying-aesthetics-market/35225/The aesthetics market is diversifying in terms of age, gender identity, and race and ethnicity.Global Aesthetics: Laser Advances
https://modernaesthetics.com/topics/energy-based-devices/global-aesthetics-laser-advances/35224/Focal point technology lasers have the potential to fill a void in the aesthetic market for darker skin types.News and Updates
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/news-and-updates/35221/New Products
https://modernaesthetics.com/topics/skincare/new-products-7/35220/AAFPRS Mission Trip to Ukraine
https://modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/aafprs-mission-trip-to-ukraine/33931/Founded in 1992, FACE TO FACE is a humanitarian and educational surgical exchange program sponsored by the Educational and Research Foundation for the American Academy of Facial Plastic and Reconstructive Surgery. Both in the United States and abroad, AAFPRS surgeons and other medical professionaMATV News: DREAM Initiative’s Forces of Beauty Report; AAFPRS Medical Mission Trip to Ukraine; Galderma’s Investigational Neurotoxin Gets High Marks
https://modernaesthetics.com/series/matv-news/matv-news-dream-initiatives-forces-of-beauty-report-aafprs-medical-mission-trip-to-ukraine-galdermas-investigational-neurotoxin-gets-high-marks/33706/Allergan Aesthetics and skinbetter science have released a new report from their DREAM Initiative. The Forces of Beauty report provides a new understanding of what inclusive and representative beauty looks like today. Plastic surgeon Kelly Bolden, MD discusses the importance of the findings. AmericaMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromUpdate on Skincare and Nutraceuticals
https://modernaesthetics.com/topics/skincare/update-on-skincare-and-nutraceuticals/35107/Expert insights on hot trends and what’s coming soon.Coming & Going: July/August 2021
https://modernaesthetics.com/topics/energy-based-devices/coming-going-julyaugust-2021/35068/